Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Organon & Co. (OGN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Organon & Co. (OGN), most recent 12 months reported: revenue $6.13B, net income $209M, free cash flow $567M. Latest balance sheet on file: liquid cash $1.13B, total debt $8.55B, net cash -$7.42B. From SEC filings. Others in Pharmaceutical Preparations: VERTEX PHARMACEUTICALS INC / MA · Bausch Health Companies Inc. · Zoetis Inc. · BEONE MEDICINES LTD. · Elanco Animal Health Incorporated · ALNYLAM PHARMACEUTICALS, INC. · Jazz Pharmaceuticals plc · Perrigo Company plc

Stock screener

Watchlist